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Quality assessment in vascular access procedures for hemodialysis is not clearly 
defined. The aim of this article is to compare various guidelines regarding 
recommendation on quality control in angiocccess surgery. 
The overall population of end stage renal disease patients and patients in need for 
hemodialysis treatment is growing every year. Chronic intermittent hemodialysis is 
still the main therapy. The formation of a functional angioaccess is the cornerstone in 
management of those patients. Native (autologous) arteriovenous fistula is the best 
vascular access available. A relatively high percentage of primary failure and fistula 
abandonment raises the need for quality control in this field of surgery.  
There are scarce recommendations of quality assessment on creation of a vascular 
access for hemodialysis in searched guidelines. Some guidelines recommend the 
proportion of native AVF in incident and prevalent patients as well as the maximum 
tolerable percentage of central venous catheters and complications. According to 
some guidelines, surgeon's experience and expertise have a considerable influence 
on outcomes. There are no specific recommendations regarding surgeon's specialty, 
grade, level of skills and experience. 
In conclusion, there is a weak recommendation in guidelines on quality control in 
vascular access surgery. Quality assessment criteria should be defined in this field of 
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surgery. According to those criteria, patients and nephrologist could choose the best 
vascular access center or surgeon. Centres with best results should be referral 
centres and centres with poorer results should implement quality improvement 
programmes.  
 




Overall population of end-stage renal disease (ESRD) patients is growing every year. 
More than 70% of those patients are treated by chronic intermittent hemodialysis 
(HD) (1). Functional vascular access (VA) to the circulation is necessary for adequate 
HD. All guidelines recommend native (autologous) arteriovenous fistula (AVF) as the 
preferred access because of a low complication rate, durability and lower cost in 
comparison to arteriovenous graft (AVG) or central venous catheter (CVC) (2-9). A 
relatively high percentage of primary failure and fistula nonmaturation rate is the most 
negative aspect of VA surgery. Quality assessment and quality indicators are not 
clearly defined in angioaccess surgery. 
Guidelines are comprehensive and hard-laboring work of experts. Recommendations 
are based on the most reliable source of high-quality evidence. Evidence – based in 
surgery can be developed from different sources. Large randomized controlled trials 
(RCTs) are generally considered the gold standard of evidence-based practice in 
surgery. Other sources are: meta-analyses, systematic literature reviews, 
observational studies, expert opinions and other (10). Various clinical practice 
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guidelines exist on VA surgery but there are no controlled randomized trials regarding 
quality assessment. 
The aim of this article is to search the most cited guidelines and find out the 
recommendations for quality control in VA procedures for HD, especially regarding  
the quality assessment of VA surgeons.   
 
Methods 
We searched Medline and Web of Science databases for published VA  guidelines of 
various scientific societies with the special interest in quality assessment.  When 
more guidelines of the same society were availale the most recent one was selected. 
The special interest was given to the following criteria: 1. surgeon´s experience; 2. 
the rate of functional VA in incident patients; 3. the rate of functional VA in prevalent 
patients; 4. access survival; 5. percentage of dialysis catheters.  
 
Results and Discussion 
 
Eight guidelines from various parts of the world were found and included into the 
analysis. Table 1.  
 
The impact of surgeon's experience 
Substantial variations of outcomes in VA surgery exist between countries. The 
DOPSS study have shown great differences in prevalence of AVF, AVG and CVC 
between facilities in United States (US) and Europe even after adjustment of age, 
gender, body mass index and comorbidities (11). There are also marked variations in 
the prevalence of AVFs and primary failure rate in small geographical areas. A study 
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conducted in the Netherlands revealed that primary failure rate varied from 8% to 
50% among 11 centres (12). Even in Japan, the nation with the highest prevalence of 
AVFs and the lowest prevalence of CVCs, great differences in outcomes was found. 
The primary failure rate was reported to be 0.8–23.6% in 23 facilities (13). Some 
authors called this phenomenon as a „center effect“ (12). Spergel concluded that 
surgical judgment and technique are the most important factor affecting outcomes 
and called it the „surgeon effect“ (14). But, how  can we measure quality of a vascular 
access surgeon?  
The importance of surgeon experience in VA procedures for HD was already 
recognized (15,16). The problem occurs, when the specific factors influencing 
surgeon's quality are trying to be objectivised. Some of the quality indicators actually 
depend on the caring nephrologist  more than on the VA surgeon. The specialty, 
grade, level of education, skills and experience of VA surgeon may influence 
outcomes. The impact of specialty of VA surgeon on quality of procedures is difficult 
to reveal. Worldwide, various specialists are involved in construction of VA for HD: 
vascular surgeons, general surgeons, urologists, transplant surgeons, interventional 
radiologists, cardiothoracic surgeons and nephrologists as a non-surgical specialty. 
Interventional nephrologists construct about 85% of the AVFs in Italy and about 25% 
of the AVFs in Japan, the nations with the highest proportion of prevalent patients 
using an AVF (17). Worldwide, it has been reported that interventional nephrologists 
have comparable or even better results than surgeons (18 - 22). It seems reasonable 
to state that dedication to angioaccess surgery is more important than specialty of VA 
surgeon. The grade of operating surgeon may also influence outcomes. One of the 
results in a DOPPS study was that the likelihood of the AVF use was 40% lower in 
dialysis unit in which surgery trainee either performed or assisted permanent VA 
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placements (11). There was an opposite finding that involvement of surgical trainees 
did not influence outcomes (23).  
Globally, the formal education and certification in VA surgery is often an exception 
than rule. Younger surgeons learn from experienced surgeons and, not so rarely, 
from their own mistakes. The main question is: which factors influence skill and 
experience. The years of surgical training are less important in comparison to the 
number and complexity of procedures performed per year. O'Hare et al. have found 
that AVF placement were over three times as high at high-volume centres (>30 
procedures per year) compared to low-volume centres (<10 procedures per year).  
(24). An experienced and dedicated surgeon can achieve good results even in 
patients with severe comorbidities (25).  
 
What guidelines suggest? 
There are no specific recommendations regarding surgeon grade, specialty or level 
of skills and experience in searched guidelines. Japanese guidelines suggest, as an 
opinion, that the access surgeon is required to have sufficient experience and 
expertise. The patency of the VA is clearly affected by the surgeon's ability. Also the 
insertion of CVC should be performed by an experienced surgeon or under guidance 
of an experienced surgeon (6). European Best Practice Guidelines (EBPG) stated, 
without grade of recommendations, that experience and detection of the physician 
performing VA surgery have a considerable influence on outcome. Catheter insertion 
must be performed by trained and senior physician (3). The UK Guidelines stated 
that AVG require planning and surgical expertise, the number of possible 
configurations ultimately depends on the expertise of the surgeon (9). 
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Canadian Guidelines suggest that the location for the graft placement is determined 
by each patients unique anatomic restrictions, previous access history, and surgeon's 
skill (8). KDOQI Guideline mentioned that longevity of AVG function might be 
influenced by surgical techniques (2). Some guidelines only recommend the rate of 
AVFs in incident and prevalent HD patients and acceptable percentage of long-term 
CVCs and catheter related complications. All guidelines recommend creation of 
native AVF as the first choice (2-9). It is crucial to stress that the rate of usable 
(functional) fistulas is the target outcome, not the construction rate (2). Among 
searched guidelines, only Spanish guidelines referred to the suggested standards as 
quality indicators. Five quality indicators were formulated. The percentage of patients 
who initiate HD with usable AVF or AVG (standard 75%), the percentage of prevalent 
patients using AVF (standard 80%), the annual thrombosis rate of AVF (standard 
0.25) and AVG (standard 0.50), the percentage of prevalent patients with tunneled 
CVC (standard <10%) and the percentage of infection of tunneled CVC (standard 
<10% in the first 3 months after insertion and <50% infections annually) (7). 
The latest UK renal association guidelines recommend that at least 60% of incident 
patients should have functioning AVF or AVG and at least 80% of all prevalent 
patients should receive dialysis treatment via definitive access: AVF, AVG or 
Tenckhoff catheter (9). Japanese Guidelines set the survival expectations of AVG. 
The goal for primary patency rates 1 year after surgery is 60%. The goal for 
secondary patency rates (assisted patency) is 80%, 60%, and 40% for 1 year, 3 
years, and 5 years, respectively (6). Canadian guidelines suggest that more than 
60% of prevalent patients should have a native AVF. Quality care standards are 
according to the Canadian guidelines defined as following target rates: the rate of 
graft thrombosis should not exceed 0.5 thrombotic episodes per patient year at risk, 
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after adjusting for initial failures (e.g., failures within the first 2 months of fistula use), 
the rate of thrombosis of native AV fistulae should be <0.25 episodes per patient year 
at risk, the rate of infection should not exceed 0.01 episodes per patient year at risk 
for primary AV fistula and 0.1 episodes per patient year at risk for AV grafts, for 
tunneled cuffed catheters, the recommended target rate of systemic infection is <0.5 
episodes per patient year at risk, the primary access failure rates of dialysis AV grafts 
in the following locations and configurations should not be <15% in forearm straight 
grafts, 10% in forearm loop grafts, and 5% in upper arm grafts. The cumulative 
patency rate of all dialysis AV grafts should be at least 70% at 1 year, 60% at 2 
years, and 50% at 3 years (8). Other searched guidelines and initiatives do not 
recommend specific quality criteria in construction of native VA. Many nephrologists 
established their own quality indicators of surgeon's quality and refer patients to the 
surgeon with good outcomes (26,27). Nguyen et al. suggested that nephrologists 
should choose the VA surgeon who is willing to create more than 50% functional 
fistulas (28). 
Generally, there is no cosensus about quality assessment criteria in VA procedures 
for HD. Searched guidelines do not recommend speciality and grade of operating 
surgeon as well as the number of procedures per year needed for having acceptable 
experience and skills.  
Despite the lack of evidence from randomized controlled trials (RCTs) about quality 
assessment in angiaccess surgery, according to some standard criteria, it is possible 
to indirectly measure the quality of vascular access care but not surgeon's quality 
directly. 
 
Should criteria for quality assessment be unique worldwide? 
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VA community should try to define realistic standards and criteria for assessment of 
quality in VA procedures for HD at national level according to local practice patterns 
and available resources. The latest UK guidelines define more realistic standards 
related to percentage of incident and prevalent patients using AVF or AVG in 
comparison to guidelines published in 2011. Former guidelines suggest the use of 
AVF in 65% of incident and 85% in prevalent patients (29). The latest guidelines 
decrease this demand to 60% in incident and 80% in prevalent patients not only 
using AVF but also AVG (9). Roca-Tey et al. have found a stable percentage of 
patients who initiate HD with a fistula (around 50%) in eleven years time span without 
tendency for increase (30). In Spanish guidelines the percentage of incident patients 
using AVF was set as high as 75% (7). 
Improvement in VA care should be a continuous process and quality assessment 
could be one of the steps towards better outcomes. Van der Veer et al. conducted an 
electronic survey among national experts from 37 European countries and have 
found that factors commonly believed to negatively affect the quality of VA care were: 
(lack of) surgical capacity; reimbursement system for establishing or maintaining VA; 
(lack of) training and education of health professionals and (lack of) requirements for 
minimum number of procedures for those creating VA (31).  
Some of the possible measurable criteria could be: specific education in VA surgery 
and license, number of procedures per year, the time between the presentation of 
patients to VA surgeon and construction of a VA, the percentage of autogenous 
fistulas, AVGs and CVCs in prevalent HD patients, the percentage of functional 
fistulas in incident HD patients, the percentage of creation of functional fistula in the 
first attempt, primary patency or intervention-free period, primary failure rate and 
number of intervention to allow patency, the percentage of patients switching from 
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CVC to AVF or AVG, the number of catheter days, maturation time and durability of 
an access may be some of the outcomes which can be measured. VA surgeon's 
dedication seems to be very important but can not be measured. A dedicated 
surgeon is open to continuous education, does not consider VA procedures as a 
minor surgery and prepare himself for each operation which includes quality 
preoperative examination and communication with the patient. Quality VA surgeon is 
familiar with all vascular access techniques and follow up patients in order to achieve 
the best outcomes. The possible characteristics of a quality VA surgeon are shown in  
Table 2. 
Table 2. Characteristics of a quality vascular access surgeon. 
Education Skills Outcomes 
Academic or referral centre 
Vascular access courses 
Training on phantom model 
Strict mentor supervision  
Ultrasound 




Proportion of AVF, AVG and CVC 
Switching rate: CVC to AVF/AVG 
Maturation rate and time 
Proportion of functional VA on 
the first attempt  
 





Because of a lack of valid trials regarding quality assessment in VA procedures, there 
are only weak recommendations in searched guidelines. According to the 
recommended proportion of native AVF in incident and prevalent HD patients and 
acceptable percentage of CVC and complication rate, it is possible to indirectly 
measure outcomes of VA surgeon(s) or VA centre(s). The outcomes mainly reflect 
the surgeon's ability to create functional VA  for HD, despite some unmeasurable and 
unknown factors influencing outcomes. Also, results may be influenced by other 
 11 
 
participants in care of HD patients as well as patients' characteristics and local 
resources. Vascular access care should be individualised  and the best vascular 
access for each individual patient should be considered having in mind that it would 
not always be a native fistula. Vascular access community should try to define criteria 
which reflect quality in VA surgery in order to allow comparison of outcomes. VA 
centres with best results should become referral centres, while centres with inferior 
results should implement quality improvement programs. The final results of quality 
improvement in angioaccess surgery will be decrease of morbidity and mortality, as 
well as costs. 
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